Mycophenolate Mofetil
NDC Package 60505-2967-3

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Mycophenolate Mofetil is mycophenolate is used in combination with other medications to keep your body from attacking and rejecting your transplanted organ (such as kidney, liver, heart). Marketed by Apotex Corp, this product is identified by NDC 60505-2967 and is authorized under FDA application ANDA090499.

Identification & Billing

NDC Package Code
60505-2967-3
Package Description
30 TABLET, COATED in 1 BOTTLE
Product Code
60505-2967
11-Digit Billing Format
60505296703

Clinical Specifications

Proprietary Name
Mycophenolate Mofetil
Dosage Form
-
Usage Information
Mycophenolate is used in combination with other medications to keep your body from attacking and rejecting your transplanted organ (such as kidney, liver, heart). It belongs to a class of medications called immunosuppressants. It works by weakening your body's defense system (immune system) to help your body accept the new organ as if it were your own.

Regulatory & Marketing

Labeler Name
Apotex Corp
FDA Application #
ANDA090499
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
05-04-2009
End Marketing Date
09-30-2012
Listing Expiration
09-30-2012
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (60505-2967). Click a package code to view its specific billing and regulatory data.

60505-2967-1
100 TABLET, COATED in 1 BOTTLE
60505-2967-5
500 TABLET, COATED in 1 BOTTLE
60505-2967-7
3500 TABLET, COATED in 1 BOTTLE
60505-2967-8
1000 TABLET, COATED in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 60505-2967-3 identifies a specific commercial package of 30 tablet, coated in 1 bottle of Mycophenolate Mofetil, labeled by Apotex Corp. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Apotex Corp on May 04, 2009. The current certification is valid through September 30, 2012.

What are the primary indications for this medication?

Mycophenolate is used in combination with other medications to keep your body from attacking and rejecting your transplanted organ (such as kidney, liver, heart). It belongs to a class of medications called immunosuppressants. It works by weakening your body's defense system (immune system) to help your body accept the new organ as if it were your own.

How is this Apotex Corp product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 60505296703. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
60505-2967-3
11-Digit CMS (5-4-2)
60505-2967-03

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.